Fantastic 8th Simon Karpatkin Memorial Lecture at ICTHIC by Prof Agnes Lee. Interesting overview of the management of cancer-associated thrombosis highlighting an exceptional career by Prof Lee. 🏆 🎉

1/ Right, ANNEXA-I has dropped. The 1st ever RCT of a reversal agent for DOACs. Randomised patients with intracranial hemorrhage to andexanet alfa or usual care. Stopped early as it met its primary endpoint.
There are A LOT of talking points - LET'S GO! nejm.org/doi/full/10.10…

Outstanding choices. Congratulations, Alisa Wolberg and Marc Carrier !!!

All you wanted to know about lupus anticoagulant but were afraid to ask. Excellent review in the current issue of RPTH. As always the PDFs of papers published in this journal are freely available to all. tinyurl.com/4dtpzc9e #lupusanticoagulant #thrombosis

Important paper in Blood Journal showing that type 1 von Willebrand disease consists of two groups, those that normalise their levels with age and those who do not. The number diagnosed depends at what age you do the testing. tinyurl.com/ye26zyhf #VWD #agerelated

Are you a healthcare provider who orders or tests serum ferritin in adult or pediatric patients?
Please take our VERY short survey: surveymonkey.com/r/DNDTQMZ
Please RT & share to help us understand the acceptability of moving to a clinical decision limit! 🎯

Dr. Michelle Sholzberg appointed Division Director – Hematology deptmedicine.utoronto.ca/news/dr-michel…

Congratulations, Dr. Michelle Michelle Sholzberg, on being appointed Division Director - Hematology in the Department of Medicine at University of Toronto! Dr. Sholzberg is also the Head of Hematology-Oncology at St. Michael's Hospital. 👏
Temerty Medicine
deptmedicine.utoronto.ca/news/dr-michel…

State of the art lecture published in RPTH…D-Dimer assays are not interchangeable! We need to educate, standardize reporting and work on a harmonization model for D-dimer results….more on this at ISTH 2024 Bangkok! @rpthjournal ISTH

For the #ISTH2024 Congress, there's a huge number of abstracts to be placed for each Congress day. Our skilled team is in Bangkok at the moment, eagerly going through this mass of exciting new information. Wow!  Looking forward to seeing you in Bangkok. @ISTH

DFCM Vice-Chairs Dr. Peter Selby and Tara Kiran have recently been awarded for their achievements in family medicine research. We spoke with both of them about their impressive careers and how others can follow in their footsteps.

More here ➡️ dfcm.utoronto.ca/news/culture-c…

Wow…Dr. Straus is an incredible role model for all scientists 💪🤩

I don't think we talk enough about how much harm copy/paste has done to the medical record.

This documentary demands we confront the stigma surrounding menstruation. ⁦Michelle Sholzberg⁩ msnbc.com/know-your-valu…

Congrats to our Dr. Peter Selby, who has received the 2023 Lifetime Achievement Award for his contributions to the field of #addiction medicine in #Canada as a leader, researcher, clinician + educator.

The Lifetime Achievement Award is the highest honour bestowed by CSAM-SMCA.

⁦Dr. Peter Selby⁩ getting a Lifetime Achievement award from the Canadian Society of Addiction Medicine! So proud 🥹 of his accomplishments, capacity building in addiction medicine in canada, humanity, mentorship to so many, humility and generosity of spirit.

via @NYTimes nytimes.com/2023/10/17/wel…

High-risk drinking is common in #Canada .

CAMH researcher Jürgen Rehm co-chaired new evidence-based guidelines published in CMAJ
enabling primary care providers to support early detection + #treatment for high-risk drinking + #alcohol use disorder.

MORE:
camh.ca/en/camh-news-a…

STRATUS Trial published JAMA
🩸Cluster trial 25 ICUs >27,000 patients
🩸Switch to “small-volume” tubes that⬇️blood drawn for lab tests may⬇️RBC transfusion↔️effect on testing
🩸Available, cost-neutral, compatible with analyzers – will you switch?
jamanetwork.com/journals/jama/…

via @NYTimes - Apixaban and Rivaroxaban made #1 and #3 !!! Whaaat? nytimes.com/2023/08/29/us/…